CA114612/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2005	2
2007	3
2008	4
2009	8
2010	13
2011	10
2012	6
2013	11
2014	5
2015	2
2016	1
2024	0

1

Magnetic nanoparticles for MRI of brain tumors.

Wang J, Huang Y, David AE, Chertok B, Zhang L, Yu F, Yang VC. Wang J, et al. Curr Pharm Biotechnol. 2012 Sep;13(12):2403-16. doi: 10.2174/138920112803341824. Curr Pharm Biotechnol. 2012. PMID: 23016645 Review.

2

Magnetic nanoparticles for tumor imaging and therapy: a so-called theranostic system.

He H, David A, Chertok B, Cole A, Lee K, Zhang J, Wang J, Huang Y, Yang VC. He H, et al. Pharm Res. 2013 Oct;30(10):2445-58. doi: 10.1007/s11095-013-0982-y. Epub 2013 Jan 24. Pharm Res. 2013. PMID: 23344909 Free PMC article. Review.

3

The ATTEMPTS delivery systems for macromolecular drugs.

Kwon YM, Li Y, Naik S, Liang JF, Huang Y, Park YJ, Yang VC. Kwon YM, et al. Expert Opin Drug Deliv. 2008 Nov;5(11):1255-66. doi: 10.1517/17425240802498059. Expert Opin Drug Deliv. 2008. PMID: 18976135 Review.

4

Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application.

He H, Ye J, Wang Y, Liu Q, Chung HS, Kwon YM, Shin MC, Lee K, Yang VC. He H, et al. J Control Release. 2014 Feb 28;176:123-132. doi: 10.1016/j.jconrel.2013.12.019. Epub 2013 Dec 27. J Control Release. 2014. PMID: 24374002 Free PMC article. Review.

5

Magnetically targeted nanoparticles for brain tumor therapy: what does the future hold?

David AE, Cole AJ, Yang VC. David AE, et al. Nanomedicine (Lond). 2011 Sep;6(7):1133-5. doi: 10.2217/nnm.11.99. Nanomedicine (Lond). 2011. PMID: 21929450 No abstract available.

6

Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery.

Huang Y, Jiang Y, Wang H, Wang J, Shin MC, Byun Y, He H, Liang Y, Yang VC. Huang Y, et al. Adv Drug Deliv Rev. 2013 Oct;65(10):1299-315. doi: 10.1016/j.addr.2012.11.007. Epub 2013 Jan 28. Adv Drug Deliv Rev. 2013. PMID: 23369828 Free PMC article. Review.

7

Cell-penetrating peptides: achievements and challenges in application for cancer treatment.

Shin MC, Zhang J, Min KA, Lee K, Byun Y, David AE, He H, Yang VC. Shin MC, et al. J Biomed Mater Res A. 2014 Feb;102(2):575-87. doi: 10.1002/jbm.a.34859. Epub 2013 Jul 30. J Biomed Mater Res A. 2014. PMID: 23852939 Free PMC article. Review.

8

Synthetic skin-permeable proteins enabling needleless immunization.

Huang Y, Park YS, Moon C, David AE, Chung HS, Yang VC. Huang Y, et al. Angew Chem Int Ed Engl. 2010 Apr 1;49(15):2724-7. doi: 10.1002/anie.200906153. Angew Chem Int Ed Engl. 2010. PMID: 20232417 Free PMC article. No abstract available.

9

Physiologically based pharmacokinetic model for T84.66: a monoclonal anti-CEA antibody.

Urva SR, Yang VC, Balthasar JP. Urva SR, et al. J Pharm Sci. 2010 Mar;99(3):1582-600. doi: 10.1002/jps.21918. J Pharm Sci. 2010. PMID: 19774657 Free article.

10

ATTEMPTS system: a macromolecular prodrug strategy for cancer drug delivery.

Huang Y, Park YS, Wang J, Moon C, Kwon YM, Chung HS, Park YJ, Yang VC. Huang Y, et al. Curr Pharm Des. 2010 Jul;16(21):2369-76. doi: 10.2174/138161210791920441. Curr Pharm Des. 2010. PMID: 20618157 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Results by year